deferoxamine has been researched along with angiotensin ii in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (25.00) | 18.7374 |
1990's | 2 (16.67) | 18.2507 |
2000's | 5 (41.67) | 29.6817 |
2010's | 1 (8.33) | 24.3611 |
2020's | 1 (8.33) | 2.80 |
Authors | Studies |
---|---|
Bellomo, G; Orrenius, S; Thor, H | 1 |
Lucchelli, PE | 1 |
Hunger, A; Keberle, H; Misra, AL | 1 |
Cappelli-Bigazzi, M; De Bruyn, VH; Dole, WP; Lamping, KG; Nuno, DW | 1 |
Gloy, J; Greger, R; Hug, MJ; Meyer, TN; Pavenstädt, H; Schollmeyer, P | 1 |
Ali, SF; Imam, SZ; Mayeux, PR; Zhang, C | 1 |
Aizawa, T; Ishizaka, N; Iso-o, N; Mori, I; Nagai, R; Noiri, E; Ohno, M; Saito, K; Sata, M | 1 |
Ishizaka, N; Matsuzaki, G; Mori, I; Nagai, R; Ohno, M; Saito, K | 1 |
Hara, M; Ishizaka, N; Matsuzaki, G; Mori, I; Nagai, R; Ohno, M; Saito, K; Sata, M | 1 |
Chen, Q; Pan, HL | 1 |
Chen, M; Dong, Z; Gao, C; Guo, X; Liu, J; Liu, P; Tang, Y; Yao, P; Zeng, H; Zhang, J; Zhou, F; Zhu, X | 1 |
Chen, WX; Feng, H; Ge, HF; Guo, C; Li, CC; Tang, XQ; Wang, B; Wang, J; Xia, M; Yin, Y | 1 |
1 trial(s) available for deferoxamine and angiotensin ii
Article | Year |
---|---|
Experimental design in clinical drug research: some practical implications.
Topics: Adipose Tissue; Aldosterone; Analysis of Variance; Angiotensin II; Biometry; Clinical Trials as Topic; Deferoxamine; Dietary Proteins; Drug Synergism; Glucose; Humans; Insulin; Methandrostenolone; Methods; Models, Theoretical; Pharmacology; Placebos | 1969 |
11 other study(ies) available for deferoxamine and angiotensin ii
Article | Year |
---|---|
Alterations in inositol phosphate production during oxidative stress in isolated hepatocytes.
Topics: Adenosine Triphosphate; Aluminum; Aluminum Chloride; Aluminum Compounds; Angiotensin II; Animals; Calcium; Chlorides; Deferoxamine; Dithiothreitol; Epinephrine; Inositol Phosphates; Liver; Male; Oxidation-Reduction; Rats; Rats, Inbred Strains; Sodium Fluoride; Sugar Phosphates; Vitamin K | 1987 |
The passage of drugs across the rat intestine in vitro.
Topics: Angiotensin II; Animals; Carbon Isotopes; Deferoxamine; Female; Glutethimide; In Vitro Techniques; Intestinal Absorption; Intestinal Mucosa; Male; Permeability; Rats; Serous Membrane; Thalidomide | 1966 |
Effect of acute hypertension in the coronary circulation: role of mechanical factors and oxygen radicals.
Topics: Angiotensin II; Animals; Biomechanical Phenomena; Blood Pressure; Catalase; Coronary Circulation; Deferoxamine; Dogs; Drug Synergism; Female; Free Radicals; Hypertension; Male; Phenylephrine; Reactive Oxygen Species; Serotonin; Superoxide Dismutase; Vasoconstriction | 1994 |
Hydrogen peroxide increases the intracellular calcium activity in rat mesangial cells in primary culture.
Topics: Adenosine Triphosphate; Angiotensin II; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antidotes; Antioxidants; Calcium; Catalase; Cells, Cultured; Chromans; Cytoplasm; Deferoxamine; Dithiothreitol; Flufenamic Acid; Glomerular Mesangium; Hydrogen Peroxide; Lanthanum; Nickel; Piperazines; Pyruvic Acid; Rats; Sulfhydryl Reagents; Vasoconstrictor Agents; Vasodilator Agents; Verapamil | 1996 |
Peroxynitrite and the regulation of Na(+),K(+)-ATPase activity by angiotensin II in the rat proximal tubule.
Topics: Angiotensin II; Animals; Deferoxamine; Dose-Response Relationship, Drug; Kidney Tubules, Proximal; Male; Nitrates; omega-N-Methylarginine; Rats; Rats, Sprague-Dawley; Reactive Nitrogen Species; Sodium-Potassium-Exchanging ATPase; Superoxide Dismutase; Uric Acid | 2002 |
Iron chelation and a free radical scavenger suppress angiotensin II-induced upregulation of TGF-beta1 in the heart.
Topics: Aldosterone; Angiotensin II; Animals; Chemokine CCL2; Deferoxamine; Enzyme Inhibitors; Ferritins; Fibrosis; Free Radical Scavengers; Gene Expression; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Iron; Iron Chelating Agents; Male; Myocardium; Oxidative Stress; Phenylurea Compounds; Protoporphyrins; Pyridines; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transforming Growth Factor beta; Transforming Growth Factor beta1; Up-Regulation; Vasoconstrictor Agents | 2005 |
Iron chelation suppresses ferritin upregulation and attenuates vascular dysfunction in the aorta of angiotensin II-infused rats.
Topics: Aldehydes; Angiotensin II; Animals; Aorta; Aortic Diseases; Apoferritins; Chemokine CCL2; Deferoxamine; Ferritins; Heme Oxygenase-1; Hypertension; Iron; Iron Chelating Agents; Iron Overload; Iron-Dextran Complex; Male; Norepinephrine; Oxidative Stress; Rats; Rats, Sprague-Dawley; Receptors, Transferrin; RNA, Messenger; Up-Regulation; Vasoconstrictor Agents; Vasodilation | 2005 |
Lipid accumulation and transforming growth factor-beta upregulation in the kidneys of rats administered angiotensin II.
Topics: Angiotensin II; Animals; Deferoxamine; Fatty Acid Synthases; Gene Expression Regulation; In Situ Hybridization; Iron; Iron Chelating Agents; Kidney; Lipid Metabolism; Lipids; Male; Plasminogen Activator Inhibitor 1; Rats; Rats, Sprague-Dawley; RNA, Messenger; Staining and Labeling; Sterol Regulatory Element Binding Protein 1; Superoxides; Tissue Distribution; Transforming Growth Factor beta; Transforming Growth Factor beta1; Up-Regulation | 2005 |
Signaling mechanisms of angiotensin II-induced attenuation of GABAergic input to hypothalamic presympathetic neurons.
Topics: 4-Aminopyridine; Analysis of Variance; Angiotensin II; Animals; Bicuculline; Deferoxamine; Drug Interactions; GABA Antagonists; gamma-Aminobutyric Acid; In Vitro Techniques; Inhibitory Postsynaptic Potentials; Laminectomy; Male; Metalloporphyrins; Neurons, Afferent; Paraventricular Hypothalamic Nucleus; Patch-Clamp Techniques; Potassium Channel Blockers; Presynaptic Terminals; Rats; Rats, Sprague-Dawley; Signal Transduction | 2007 |
Quercetin Attenuates Ethanol-Induced Iron Uptake and Myocardial Injury by Regulating the Angiotensin II-L-Type Calcium Channel.
Topics: Angiotensin II; Animals; Body Weight; Calcium Channels, L-Type; Deferoxamine; Ethanol; Heart; Iron; Male; Mice; Mice, Inbred C57BL; Myocardium; Quercetin | 2018 |
Iron chelation suppresses secondary bleeding after intracerebral hemorrhage in angiotensin II-infused mice.
Topics: Angiotensin II; Animals; Cerebral Hemorrhage; Deferoxamine; Drug Combinations; Hemoglobins; Hypertension; Intracranial Hemorrhages; Iron Chelating Agents; Iron Overload; Iron-Dextran Complex; Male; Mice; Mice, Inbred C57BL; Microinjections; Muscle Contraction; Muscle, Smooth, Vascular; Neostriatum; Polyvinyls; Tantalum; Vasoconstrictor Agents | 2021 |